Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group.

Elena Del AlcázarAnna López-FerrerÁlvaro Martínez-DoménechMarc JuliàRicardo Ruiz-VillaverdeLourdes Rodríguez Fernández-FreireJaime NotarioMar Llamas-VelascoMarta FerranY José Manuel Carrascosa

Published in: The Journal of dermatological treatment (2022)

Keyphrases

cross sectional
atopic dermatitis
early onset
stem cells
free survival
bone marrow
cell therapy